Single User License
INR 135120
Site License
INR 270240
Corporate User License
INR 405360

Service Tax Additional

select a format
Price

Single User License
USD 2000
Site License
USD 4000
Corporate User License
USD 6000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Iron Deficiency Anemia-Pipeline Review, H1 2015

Iron Deficiency Anemia-Pipeline Review, H1 2015


  Request for Sample Report

Executive Summary

Iron Deficiency Anemia-Pipeline Review, H1 2015

Summary

Global Markets Direct's, 'Iron Deficiency Anemia-Pipeline Review, H1 2015', provides an overview of the Iron Deficiency Anemia's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Iron Deficiency Anemia

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Iron Deficiency Anemia and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Iron Deficiency Anemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Iron Deficiency Anemia pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Iron Deficiency Anemia

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Iron Deficiency Anemia pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Iron Deficiency Anemia Overview 6

Therapeutics Development 7

Pipeline Products for Iron Deficiency Anemia-Overview 7

Pipeline Products for Iron Deficiency Anemia-Comparative Analysis 8

Iron Deficiency Anemia-Therapeutics under Development by Companies 9

Iron Deficiency Anemia-Therapeutics under Investigation by Universities/Institutes 10

Iron Deficiency Anemia-Pipeline Products Glance 11

Late Stage Products 11

Clinical Stage Products 12

Early Stage Products 13

Iron Deficiency Anemia-Products under Development by Companies 14

Iron Deficiency Anemia-Products under Investigation by Universities/Institutes 15

Iron Deficiency Anemia-Companies Involved in Therapeutics Development 16

Panion & Bf Biotech Inc 16

Rockwell Medical, Inc. 17

Vifor Pharma AG 18

Iron Deficiency Anemia-Therapeutics Assessment 19

Assessment by Monotherapy Products 19

Assessment by Route of Administration 20

Assessment by Molecule Type 22

Drug Profiles 24

ferric carboxymaltose-Drug Profile 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

ferric citrate-Drug Profile 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

ferric pyrophosphate citrate-Drug Profile 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

NSC-8679-Drug Profile 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Proteins to Activate Erythroferrone for Iron Deficiency Anemia-Drug Profile 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

ST-10-Drug Profile 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

VIT-91-Drug Profile 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Iron Deficiency Anemia-Recent Pipeline Updates 35

Iron Deficiency Anemia-Dormant Projects 49

Iron Deficiency Anemia-Product Development Milestones 50

Featured News & Press Releases 50

Dec 15, 2014: American Regent's Injectafer (ferric carboxymaltose injection) Assigned J Code by Centers for Medicare & Medicaid Services 50

Dec 08, 2014: American Regent Announces Clinical Data Presentations at ASH 2014 51

Nov 11, 2014: Three clinical Presentations Highlight Novel Iron Replacement Drug Triferic at ASN 53

Oct 09, 2014: Rockwell Medical Announces FDA Advisory Committee Review of Triferic For The Treatment Of Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patients 54

Sep 01, 2014: CONFIRM-HF study demonstrates that Ferinject improves exercise capacity in patients with chronic heart failure 54

Jul 15, 2014: American Regent's Injectafer (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States 55

Jun 09, 2014: Rockwell Medical Wins Appeal for Determination as Small Business for New Drug Application Filing for Triferic 56

Jun 02, 2014: Faster, more affordable treatment for Iron Deficiency Anaemia now available in Australia 57

May 28, 2014: Rockwell Medical Announces FDA Acceptance for Filing of Triferic New Drug Application 58

May 22, 2014: Keryx Receives Notification of PDUFA Date Extension for Zerenex 58

Appendix 59

Methodology 59

Coverage 59

Secondary Research 59

Primary Research 59

Expert Panel Validation 59

Contact Us 60

Disclaimer 60

List of Tables

Number of Products under Development for Iron Deficiency Anemia, H1 2015 7

Number of Products under Development for Iron Deficiency Anemia-Comparative Analysis, H1 2015 8

Number of Products under Development by Companies, H1 2015 9

Number of Products under Investigation by Universities/Institutes, H1 2015 10

Comparative Analysis by Late Stage Development, H1 2015 11

Comparative Analysis by Clinical Stage Development, H1 2015 12

Comparative Analysis by Early Stage Development, H1 2015 13

Products under Development by Companies, H1 2015 14

Products under Investigation by Universities/Institutes, H1 2015 15

Iron Deficiency Anemia-Pipeline by Panion & Bf Biotech Inc, H1 2015 16

Iron Deficiency Anemia-Pipeline by Rockwell Medical, Inc., H1 2015 17

Iron Deficiency Anemia-Pipeline by Vifor Pharma AG, H1 2015 18

Assessment by Monotherapy Products, H1 2015 19

Number of Products by Stage and Route of Administration, H1 2015 21

Number of Products by Stage and Molecule Type, H1 2015 23

Iron Deficiency Anemia Therapeutics-Recent Pipeline Updates, H1 2015 35

Iron Deficiency Anemia-Dormant Projects, H1 2015 49

List of Figures

Number of Products under Development for Iron Deficiency Anemia, H1 2015 7

Number of Products under Development for Iron Deficiency Anemia-Comparative Analysis, H1 2015 8

Number of Products under Development by Companies, H1 2015 9

Comparative Analysis by Late Stage Development, H1 2015 11

Comparative Analysis by Early Stage Products, H1 2015 13

Assessment by Monotherapy Products, H1 2015 19

Number of Products by Top 10 Routes of Administration, H1 2015 20

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 21

Number of Products by Top 10 Molecule Types, H1 2015 22

Number of Products by Stage and Top 10 Molecule Types, H1 2015 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Panion & Bf Biotech Inc

Rockwell Medical, Inc.

Vifor Pharma AG

Iron Deficiency Anemia Therapeutic Products under Development, Key Players in Iron Deficiency Anemia Therapeutics, Iron Deficiency Anemia Pipeline Overview, Iron Deficiency Anemia Pipeline, Iron Deficiency Anemia Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com